0001675100-18-000003.txt : 20180716 0001675100-18-000003.hdr.sgml : 20180716 20180713202301 ACCESSION NUMBER: 0001675100-18-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180716 DATE AS OF CHANGE: 20180713 EFFECTIVENESS DATE: 20180716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jecure Therapeutics, Inc. CENTRAL INDEX KEY: 0001698655 IRS NUMBER: 811341025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-316893 FILM NUMBER: 18953425 BUSINESS ADDRESS: STREET 1: 3210 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-750-0045 MAIL ADDRESS: STREET 1: 3210 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001698655 Jecure Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 SAN DIEGO CA CALIFORNIA 92121 619-541-8694 DELAWARE None None Corporation true 2015 Jeffrey Stafford, Ph.D. c/o Jecure Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Director James Veal, Ph.D. c/o Jecure Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Ariel Feldstein, M.D. c/o Jecure Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Thomas Woiwode, Ph.D. One Sansome Street, Suite 3630 San Francisco CA CALIFORNIA 94104 Director Bradley Bolzon, Ph.D. c/o Jecure Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 San Diego CA CALIFORNIA 94104 Director Biotechnology Decline to Disclose 06b false 2018-07-09 false true true true false 0 3000000 3000000 0 false 4 0 0 0 false Jecure Therapeutics, Inc. /s/ Jeffrey A. Stafford, Ph.D. Jeffrey A. Stafford, Ph.D. Chief Executive Officer 2018-07-12